Biocon’s subsidiary Syngene has developed testing technology for coronavirus which it says provides better results than existing technology. The company is in discussions with test-kit manufacturers to bring the technology to market.from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/2Zgrfg1
